Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1049 | 1086 | 1119 | 1144 | 1228 | 1945 |
Fund Return | 4.88% | 8.64% | 11.88% | 4.59% | 4.2% | 6.88% |
Place in category | 5119 | 5210 | 4780 | 4085 | 3266 | 1565 |
% in Category | 74 | 77 | 79 | 88 | 97 | 82 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Portfolio Management SOLIDE A | 744.4M | 0.86 | -0.12 | 2.27 | ||
Portfolio Management SOLIDE T | 744.4M | 0.86 | -0.12 | 2.28 | ||
KEPLER Vorsorge Mixfonds A | 670.13M | 1.74 | 1.34 | 4.24 | ||
KEPLER Vorsorge Mixfonds T | 670.13M | 1.74 | 1.34 | 4.24 | ||
KEPLER Risk Select Aktienfonds A | 314.79M | 6.87 | 5.33 | 8.46 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Raiffeisen Nachhaltigk Aktien R VT | 1.56B | 4.05 | 3.89 | 7.66 | ||
Apollo Styrian Global Equity A2 A | 619.13M | 11.82 | 11.32 | 11.69 | ||
KEPLER Risk Select Aktienfonds A | 314.79M | 6.87 | 5.33 | 8.46 | ||
KEPLER Risk Select Aktienfonds T | 314.79M | 6.87 | 5.33 | 8.46 | ||
KCM Aktien Global SRI I T | 179.17M | 11.76 | 11.35 | 11.72 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 3.18 | 777.71 | +1.44% | |
AbbVie | US00287Y1091 | 2.18 | 162.54 | -0.12% | |
Accenture | IE00B4BNMY34 | 2.16 | 310.66 | +1.50% | |
Amgen | US0311621009 | 2.09 | 300.30 | +0.27% | |
Hannover Rueckversicherung SE | DE0008402215 | 1.92 | 229.70 | -1.33% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review